CACLP is a highly influential and concentrated professional exhibition in the field of in vitro diagnostics. After nearly 20 years of development, with the joint efforts of the organizer and all participating companies, it has grown into a flagship expo event in the IVD field. The conference is characterized by a large amount of information, high popularity, strong professionalism, large scale, and a collection of the entire industry chain. It has played an irreplaceable role in the promotion, sales, transformation, promotion, and cooperation of in vitro diagnostic products.CACLP is a grand event that intensively displays IVD products and truly reflects the progress and development of the industry! It is a grand event where the IVD brand is fully present and energetic, covering the entire industry chain, exploring business development opportunities, and collecting cutting-edge information!It is a grand meeting to build sales channels and establish personal connections to help companies move forward in production, learning, research, application, and transformation to talk about the future of laboratory medicine!

In July 2020, Auchen Biotech will reunite with you in Nanchang to share the feast of in vitro diagnostics, and build a better tomorrow for in vitro diagnostics with the power of the brand!

During the exhibition, Ningbo Aocheng will bring the latest products——The placental growth factor (PLGF) test reagent was unveiled at the exhibition.

New testing products approved by Ningbo Aocheng Biotechnology Co., Ltd.——Placental growth factor (PLGF) detection kit (immunofluorescence method)——

Obtained the "Practical Guidelines for Early Preeclampsia Screening and Prevention in Early Pregnancy" issued by the International Federation of Obstetrics and Gynecology (FIGO) in 2019 and the "Hypertensive Disorders in Pregnancy" issued by the Obstetrics and Gynecology Branch of the Chinese Medical Association in 2020 The strongest level recommendation in the "Guide to Diagnosis and Treatment" has opened a new chapter in the scientific and standardized management of hypertension and preeclampsia during pregnancy in my country.

The Aucheer iRate PLGF test reagent can help clinicians more reasonably carry out risk stratification and clinical assessment of high-risk factors and pregnant women with suspected preeclampsia, strengthen preeclampsia management, reduce or delay the occurrence and development of preeclampsia, and ensure mother-fetal safety.